Anosmia and Upper Limb Rigidity-A Potential Phenotype of Idiopathic Normal Pressure Hydrocephalus with Cerebrospinal Fluid α-Synuclein Seeds
- PMID: 40200913
- PMCID: PMC12160991
- DOI: 10.1002/mds.30184
Anosmia and Upper Limb Rigidity-A Potential Phenotype of Idiopathic Normal Pressure Hydrocephalus with Cerebrospinal Fluid α-Synuclein Seeds
Abstract
Background: The pathophysiology of idiopathic normal pressure hydrocephalus (iNPH) and its association with neurodegenerative disorders is poorly understood.
Objectives: The aim was to determine the prevalence of α-synuclein pathology in iNPH and its associations with clinical characteristics.
Methods: We used α-synuclein seed amplification assay (synSAA) to retrospectively analyze cerebrospinal fluid (CSF) from a large single-center iNPH cohort (n = 144). Clinical assessments comprised Unified Parkinson's Disease Rating Scale part III, Mini-Mental State Examination, levodopa-challenge test, and olfactory identification test. Degenerative biomarkers (total-tau, phospho-tau, β-amyloid 1-42, and β-amyloid 1-40) were measured in CSF.
Results: A total of 30.1% of iNPH patients were synSAA+, and presented significantly more upper limb (UL) rigidity, hallucinations, and worse olfactory performance than synSAA- cases. Anosmia was higher in synSAA+ patients (64.0%) than synSAA- patients (15.3%). Clinical assessments and other biomarkers did not significantly vary with synSAA status.
Conclusions: Underlying α-synuclein pathology is common in iNPH and presents with UL rigidity and olfactory dysfunction, suggesting a distinct synSAA+ phenotype in iNPH. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Keywords: SAA; anosmia; normal pressure hydrocephalus; seed amplification assay; α‐synuclein.
© 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Figures
References
-
- Fasano A, Espay AJ, Tang‐Wai DF, Wikkelsö C, Krauss JK. Gaps, controversies, and proposed roadmap for research in Normal pressure hydrocephalus. Mov Disord 2020;35(11):1945–1954. - PubMed
-
- Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PML. Diagnosing idiopathic Normal‐pressure hydrocephalus. Neurosurgery 2005;57(3):4–16. - PubMed
-
- Trenkwalder C. Starnberg trial on epidemiology of parkinsonism and hypertension in the elderly: prevalence of Parkinson's disease and related disorders assessed by a door‐to‐door survey of inhabitants older than 65 years. Arch Neurol 1995;52(10):1017–1022. 10.1001/archneur.1995.00540340109020 - DOI - PubMed
-
- Espay AJ, Da Prat GA, Dwivedi AK, et al. Deconstructing normal pressure hydrocephalus: ventriculomegaly as early sign of neurodegeneration. Ann Neurol 2017;82:503–513. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
